Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Disciplinary Actions topic

No spam. Unsubscribe anytime.

Medical board opens multiple investigations, orders expert reviews and approves 24-month consent agreement with monitoring and chaperone requirement

Arkansas State Medical Board · December 4, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The board moved a broad enforcement docket: it opened expert reviews and investigations, initiated show-cause proceedings for several practitioners, issued an emergency order suspension for a physician with concerning neurocognitive findings, and negotiated a consent agreement requiring 24 months of monitoring, mandatory chaperones and six-month updates for a physician returning under AMF/Acumen oversight.

The Arkansas State Medical Board advanced an extensive enforcement agenda during the meeting, opening expert reviews and investigations, issuing show-cause orders and, in one case, an emergency order suspension (EOS) based on a consultant's neurocognitive assessment.

In a high-profile case the board's counsel and the Arkansas Medical Foundation/Acumen advocated for a consent agreement for a physician whose underlying criminal charges were dismissed; Acumen told the board the practitioner had completed the initial phase of a longitudinal program and that the monitoring contract (with AMF) remained in effect. Counsel proposed that the board adopt a consent order requiring compliance with the AMF/Acumen monitoring and additional safeguards.

Board members debated duration and safeguards. Several members asked for stronger protections: a chaperone requirement for patient encounters, site-approval for any practice location, and periodic updates. Defense counsel agreed to extend monitoring obligations if the board required them. The board voted to propose a 24-month consent agreement that codified the AMF/Acumen monitoring obligations, mandated chaperones for patient encounters (male or female), and required six-month in-person updates to the board; the agreement also preserved the board's ability to take further action on violation.

Separately the board accepted expert recommendations in multiple matters (some found no gross negligence); it authorized expert reviews and show-cause proceedings where experts flagged potential safety concerns. For one physician the board issued an immediate EOS after a consultant reported 'glaring deficits' on neurocognitive testing; the EOS takes effect pending the supplement of formal reports and is intended to protect patients while the board gathers records and expert opinion.

What happens next: The board's legal and investigative staff will request records, identify and retain outside experts where needed, and schedule show-cause hearings or receive updates under consent agreements as appropriate. Several cases were tabled pending receipt of expert reports or completion of monitoring program milestones.